Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BIOSECURE Act
Pharma
AbbVie-FutureGen, Takeda, Kyowa Kirin—Fierce Pharma Asia
AbbVie ventures into TL1A via a Chinese biotech. An ex-Takeda staffer pleaded guilty to scamming the firm. Kyowa Kirin will invest $530 million in NC.
Angus Liu
Jun 14, 2024 5:00am
WuXi shares jump after BIOSECURE's exclusion from defense bill
Jun 12, 2024 12:58pm
BIO CEO talks BIOSECURE Act, trade group reorg
Jun 7, 2024 10:33am